IP Library Granted Patent US 9,790,548
Granted Patent B2
US 9,790,548 · App. 14/182,975 · Granted Oct 17, 2017

Methods and devices for amplification of nucleic acid

Inventors: Steven Gordon (Weston, MA); Daniel Stetson (Stow, MA)
Assignee: Intelligent Biosystems Inc.
C12Q1/6874B01L3/50851B01L3/50853C12Q1/686C12Q1/6837C12Q1/6869B01L7/52B01L2200/0689B01L2300/0819C40B50/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,790,548
App. No.
14/182,975
Granted
Oct 17, 2017
Kind
B2
Abstract

The present invention relates to methods and devices for amplifying nucleic acid, and, in particular, amplifying so as to generate products on a surface without the use of emulsions. In a preferred embodiment, a plurality of groups of amplified product are generated on the surface, each group positioned in different (typically predetermined) locations on said surface so as to create an array.

Claims (12)

1. A method of amplifying and sequencing nucleic acid, comprising:

a) providing i) a population of different nucleic acid template molecules, ii) a plurality of first and second single stranded oligonucleotides immobilized on a glass surface, iii) amplification reagents, iv) sequencing reagents, and v) a plurality of first and second sequencing primers;

b) hybridizing at least a portion of said population of nucleic acid template molecules to said plurality of first oligonucleotides immobilized on said glass surface;

c) amplifying said nucleic acid template molecules so as to create a plurality of forward and reverse single stranded strands;

d) sequencing said forward oligonucleotide strands with said first sequencing primers; and

e) sequencing said reverse oligonucleotide strands with said second sequencing primers.

2. The method of claim 1 , wherein said amplification reagents comprise polymerase And dNTPs.

3. The method of claim 1 , wherein said sequencing reagents comprise reagents for sequencing by synthesis.

4. The method of claim 1 , wherein said plurality of first and second single stranded oligonucleotides are immobilized to said glass surface through a linker.

5. The method of claim 4 , wherein said linker elevates said oligonucleotides away from said glass surface.

6. The method of claim 1 , wherein when the first sequencing primers are used in step

d), said second sequencing primers are not active.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Mar 24, 2023
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: ISOPLEXIS CORPORATION
Reel/Frame 063235/0942 →
PATENT PURCHASE AGREEMENT Recorded Jul 30, 2021
From: QIAGEN SCIENCES, LLC
To: ISOPLEXIS CORPORATION
Reel/Frame 057043/0629 →
SECURITY AGREEMENT Recorded May 28, 2021
From: ISOPLEXIS CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS III, LP
Reel/Frame 056421/0929 →
MERGER Recorded Nov 8, 2018
From: QIAGEN WALTHAM, INC.
To: QIAGEN SCIENCES, LLC
Reel/Frame 047923/0815 →
CHANGE OF NAME Recorded May 17, 2018
From: INTELLIGENT BIO-SYSTEMS, INC.
To: QIAGEN WALTHAM, INC.
Reel/Frame 047132/0861 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2014
From: GORDON, STEVEN; STETSON, DANIEL
To: INTELLIGENT BIO-SYSTEMS, INC.
Reel/Frame 032462/0086 →
Continuity (3)
Continuation 12370154 · Feb 12, 2009
Provisional Application 61029780 · Feb 19, 2008
Related Publication 20140235485A1 · Aug 21, 2014